The investor rights law firm said it is examining potential breaches of fiduciary duties by TransMedics Group directors and officers and is seeking contact from current shareholders.
Rosen Law Firm said it is investigating potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. Current holders of TransMedics Group stock were directed to the firm's website for more information and given contact details for Phillip Kim. The announcement is framed as an investor outreach notice tied to possible shareholder claims, a process that can precede shareholder derivative litigation over alleged misconduct by corporate leadership.